NIH Funding Opportunities
Notice of Special Interest: Epidemiology and Prevention in Alcohol Research
Notice NOT-AA-20-017 from the NIH Guide for Grants and Contracts
Mon, 13 Jul 2020 01:31:46 EST
Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)
Notice NOT-DK-20-035 from the NIH Guide for Grants and Contracts
Mon, 13 Jul 2020 03:53:20 EST
Grant and Contract Submission Requirements Regarding the Updated AVMA Guidelines for the Euthanasia of Animals: 2020 Edition
Notice NOT-OD-20-143 from the NIH Guide for Grants and Contracts
Mon, 13 Jul 2020 08:57:15 EST
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed
Funding Opportunity RFA-DA-21-026 from the NIH Guide for Grants and Contracts. Recent technical advancements have enabled generating human cell-mice chimeric brains by engrafting human iPSC-derived primitive neural progenitor cells and/or cord blood-derived microglial progenitor cells into neonatal mouse. In the chimeric brain, human neural progenitor cells or microglial cells differentiate, migrate, and distribute throughout the mouse brain. They are eventually functionally integrated into various brain regions. Such successes provide opportunities to define the structure, function, genetics and plasticity of functional neural networks containing human cells. It can also serve as a rodent model to study HIV infectivity, provirus activity, reservoir formation, and the neuropathogenesis of HIV infection. It allows the study of HIV and substance abuse comorbidity in the brain of a fully functional, awake, behaving animal from the single cell to neural circuitry levels.
Mon, 13 Jul 2020 01:49:16 EST
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-256 from the NIH Guide for Grants and Contracts. The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAIDs vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAIDs emergency appropriation provided by The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and The Coronavirus Aid, Relief and Economic Security (CARES) Act.
Mon, 13 Jul 2020 01:25:40 EST